1 st Annual Treatment-Related Adverse Events Symposium: FOCUS ON MANAGEMENT. Friday, October 27, Zuckerman Research Center, New York City

Transcription

1 1 st Annual Treatment-Related Adverse Events Symposium: FOCUS ON MANAGEMENT Friday, October 27, 2017 Zuckerman Research Center, New York City

2 1 st Annual Treatment-Related Adverse Events Symposium: FOCUS ON MANAGEMENT COURSE OVERVIEW Systemic anticancer therapies (cytotoxic chemotherapies, targeted therapies, immunotherapies), radiation, and therapeutic transplants have resulted in remarkable improvements in patient survival. Despite this remarkable success, the majority of patients will develop toxicities of various organ systems, which may impact overall health and activities of daily living, resulting in inconsistent antineoplastic therapy, all of which may affect clinical outcome. Therefore, prevention and management of untoward events is critical for the maintenance of quality of life and the optimization of anticancer therapies. TARGET AUDIENCE This course is intended for physicians and healthcare professionals in Breast Medical Oncology, Gastrointestinal Oncology, Genitourinary Oncology, Gynecologic Oncology, Head and Neck Oncology, Hematology & Oncology, Medical Oncology, Neuro-Oncology, and Palliative Medicine. EDUCATIONAL OBJECTIVES Recognize the clinical presentation, impact on quality of life, and grading of treatment-related adverse events in cancer patients Understand mechanisms and interventions to prevent and treat acute and chronic adverse events in cancer patients and survivors Discuss procedures and clinical tools to assess treatment-related toxicities in cancer patients

3 SYMPOSIUM HIGHLIGHTS Therapy-related adverse events will affect the majority of treated patients, resulting in increased cost, inconsistent dosing, and decreased quality of life. There is no formal curriculum on adverse event management in most training programs, including residencies, specialties or fellowships. With increased survival and patients living longer on therapy than ever before, adverse events affecting quality of life command attention. This symposium provides up to date information on adverse event mechanisms and management, from specialists in the most commonly affected organ systems. Practical tools to help maintain patients quality of life and dose intensity will be highlighted for the most frequently occurring events.

4 COURSE FACULTY MSK COURSE DIRECTOR Mario E. Lacouture, MD Member, Memorial Hospital Director, Oncodermatology Program Dermatology Service Department of Medicine COURSE FACULTY Thomas Atkinson, PhD Counseling Center Kathryn Ciccolini, RN Dermatology Service Christian Custodio, MD Rehabilitation Medicine Service Cherry L. Estilo, DMD Dental Service David Fernandez, MD Division of Rheumatology Hospital for Special Surgery James Flory, MD Endocrinology Service Jasmine Francis, MD Ophthalmic Oncology Service Ilya Glezerman, MD Renal Service Lee Jones, PhD Attending Physiologist Director, Cardio-Oncology Research Program Timothy Mainardi, MD Allergist and Immunologist, NewYork-Presbyterian/ Weill Cornell Medical Center Simon Mantha, MD, MPH Hematology Service Robin Mendelsohn, MD Gastroenterology and Nutrition Service Emily Tonorezos, MD, MPH General Internal Medicine Service Efstathia Tzatha, MD Neurology Service Anthony Yu, MD Cardiology Service

5 SCIENTIFIC AGENDA 8:00 am REGISTRATION 8:30 am Introduction Mario E. Lacouture, MD 8:40 am Adverse Events Grading and Patient Reporting Thomas Atkinson, PhD 9:00 am Triage and Acute Evaluations Kathryn Ciccolini, RN 9:20 am Gastrointestinal Toxicities Robin Mendelsohn, MD 9:40 am Cardiac Toxicities Anthony F. Yu, MD 10:00 am Questions and Answers 10:20 am COFFEE BREAK 10:40 am Renal Toxicities Ilya G. Glezerman, MD 11:00 am Endocrinopathies James Flory, MD 11:20 am Coagulation Toxicities Simon Mantha, MD, MPH 11:40 am Oral Toxicities Cherry L. Estilo, DMD 12:00 pm LUNCH 1:00 pm Peripheral Neuropathy Efstathia Tzatha, MD 1:20 pm Dermatologic Toxicities Mario E. Lacouture, MD 1:40 pm Rheumatologic Toxicities David Fernandez, MD 2:00 pm Exercise as Treatment Lee Jones, PhD 2:20 pm Questions and Answers 2:40 pm BREAK 3:00 pm Ocular Toxicities Jasmine H. Francis, MD 3:20 pm Long-Term Effects Emily S. Tonorezos, MD, MPH 3:40 pm Hypersensitivity Reactions Timothy Mainardi, MD 4:00 pm Lymphedema Christian Custodio, MD 4:20 pm Discussion 5:00 pm ADJOURN

6 REGISTRATION EARLY* GENERAL Physicians (MDs, PhDs and DOs) $250 $300 Nurses and Other Healthcare Providers $200 $250 Fellows and Resident $150 $200 Industry Professionals* $525 $525 *Early Rate Expires 8/1/17 REGISTER ONLINE: REGISTRATION DETAILS 30% Discounted Rate for MSK Alumni and MSK Alliance Members MSK offers a 30% discounted rate to all MSK Alumni and MSK Alliance members to attend a CME course. Please contact cme@mskcc.org for a promo code or more information. MSK Staff Registration Registration is complimentary for MSK staff who wish to attend this course. However, you must register online by visiting the course website. *Industry Members Registration is complimentary for MSK staff. However, you must register online by visiting the course website, ACCREDITATION STATEMENT MSK is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. AMA CREDIT DESIGNATION STATEMENT MSK designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credits. Physicians should only claim credit commensurate with the extent of their participation in the activity. FACULTY DISCLOSURE It is the policy of MSK to make every effort to insure balance, independence, objectivity, and scientific rigor in all continuing medical education activities which it sponsors as an ACCME accredited provider. In accordance with ACCME guidelines and standards, all faculty participating in an activity sponsored by MSK are expected to disclose any significant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services which are discussed by the faculty members in an educational presentation. As required by the ACCME, when an unlabeled use of a commercial product or an investigational use not yet approved for any purpose is discussed during an educational activity, MSK requires the speaker to disclose that the product is not labeled for the use under discussion or that the product is still investigational. ACCOMMODATIONS For information regarding traveling to MSK, including hotels in the area of MSK with discounted rates, please visit: CONTINUING MEDICAL EDUCATION MEMORIAL SLOAN KETTERING CANCER CENTER 633 Third Avenue, 12th Floor, New York, NY cme@mskcc.org MSK CME LinkedIn Group